Circassia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is p; its P/E ratio is ―; Circassia Pharmaceuticals is scheduled to report earnings on September 29, 2022, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Income Statement	-
Total Revenue	£ 27.90M	£ 23.90M	£ 34.60M	£ 48.30M	£ 46.30M
Gross Profit	£ 19.00M	£ 16.30M	£ 25.50M	£ 39.40M	£ 36.30M
EBIT	£ -2.00M	£ -18.30M	£ -27.50M	£ -43.90M	£ -71.50M
EBITDA	£ 2.90M	£ -9.30M	£ -12.30M	£ -39.50M	£ -66.60M
Net Income Common Stockholders	£ 3.60M	£ -33.50M	£ -48.30M	£ -117.10M	£ -99.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 7.40M	£ 12.60M	£ 27.00M	£ 40.70M	£ 59.50M
Total Assets	£ 86.40M	£ 103.10M	£ 246.80M	£ 307.40M	£ 402.40M
Total Debt	£ 400.00K	£ 1.40M	£ 1.70M	£ 111.40M	£ 0.00
Net Debt	£ -7.00M	£ -11.20M	£ -25.30M	£ 70.70M	£ -59.50M
Total Liabilities	£ 19.60M	£ 37.00M	£ 162.00M	£ 181.50M	£ 177.60M
Stockholders Equity	£ 66.10M	£ 66.80M	£ 84.80M	£ 125.90M	£ 224.80M
Cash Flow	-
Free Cash Flow	£ 1.20M	£ -24.40M	£ -35.40M	£ -41.00M	£ -58.40M
Operating Cash Flow	£ 1.40M	£ -23.90M	£ -25.10M	£ -40.60M	£ -57.60M
Investing Cash Flow	£ -200.00K	£ -500.00K	£ -9.90M	£ 15.60M	£ 5.20M
Financing Cash Flow	£ 4.10M	£ 4.30M	£ 21.90M	£ 20.30M	£ -1.60M

Currency in GBP

Circassia Pharmaceuticals Earnings and Revenue History

Income Statement >

Circassia Pharmaceuticals Debt to Assets

Balance Sheet >

Circassia Pharmaceuticals Cash Flow

Cash Flow >

Circassia Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing